{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:51:51Z","timestamp":1788483111249,"version":"build-2803163510"},"reference-count":17,"publisher":"Society of Nuclear Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Nucl. Med.\n                Technol."],"accepted":{"date-parts":[[2026,7,8]]},"published-print":{"date-parts":[[2026,9]]},"DOI":"10.2967\/jnmt.126.272918","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:50:22Z","timestamp":1785862222000},"page":"252-259","source":"Crossref","is-referenced-by-count":2,"title":["Preparing for Practice, Part 2: A Simulation-Based Curriculum Framework for Radiopharmaceutical Therapy Education\u2014A Program Improvement Initiative"],"prefix":"10.2967","volume":"54","author":[{"given":"Julie Dawn","family":"Bolin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"2026090306152264000_54.3.252.1","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.126.273390"},{"key":"2026090306152264000_54.3.252.2","unstructured":"Lutathera [package insert]. Food and Drug Administration website. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/208700Orig1s032lbl.pdf. Revised November 2024. Accessed July 15, 2026."},{"key":"2026090306152264000_54.3.252.3","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0b013e318217e119"},{"key":"2026090306152264000_54.3.252.4","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.125.271962"},{"key":"2026090306152264000_54.3.252.5","unstructured":"Novartis RLT Institute. Providing and administering RLT: preadministration. Novartis Pharmaceuticals Corporation website. https:\/\/www.rltinstitute.novartis.com\/providing-and-administering-rlt\/preadministration. Accessed April 30, 2026."},{"key":"2026090306152264000_54.3.252.6","unstructured":"Novartis RLT Institute. Providing and administering RLT: safe handling. Novartis Pharmaceuticals Corporation website. https:\/\/www.rltinstitute.novartis.com\/providing-and-administering-rlt\/receiving-handling-and-storage\/safe-handling\/#chapter. Accessed April 30, 2026."},{"key":"2026090306152264000_54.3.252.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.118.221846"},{"key":"2026090306152264000_54.3.252.8","unstructured":"Novartis RLT Institute. Providing and administering RLT: administration precautions. Novartis Pharmaceuticals Corporation website. https:\/\/www.rltinstitute.novartis.com\/providing-and-administering-rlt\/administration-precautions\/#chapter. Accessed April 30, 2026."},{"key":"2026090306152264000_54.3.252.9","unstructured":"Novartis RLT Institute. Providing and administering RLT: RLT administration overview. Novartis Pharmaceuticals Corporation website. https:\/\/www.rltinstitute.novartis.com\/providing-and-administering-rlt\/rlt-administration\/overview\/#chapter. Accessed April 30, 2026."},{"key":"2026090306152264000_54.3.252.10","unstructured":"Novartis RLT Institute. Providing and administering RLT: RLT administration\u2014syringe method. Novartis Pharmaceuticals Corporation website. https:\/\/www.rltinstitute.novartis.com\/providing-and-administering-rlt\/rlt-administration\/syringe-method\/#chapter. Accessed April 30, 2026."},{"key":"2026090306152264000_54.3.252.11","unstructured":"Novartis RLT Institute. Providing and administering RLT: RLT administration\u2014gravity method. Novartis Pharmaceuticals Corporation website. https:\/\/www.rltinstitute.novartis.com\/providing-and-administering-rlt\/rlt-administration\/gravity-method\/#chapter. Accessed April 30, 2026."},{"key":"2026090306152264000_54.3.252.12","unstructured":"Novartis RLT Institute. Providing and administering RLT: RLT administration\u2014peristaltic pump method. Novartis Pharmaceuticals Corporation website. https:\/\/www.rltinstitute.novartis.com\/providing-and-administering-rlt\/rlt-administration\/peristaltic-pump-method\/#chapter. Accessed April 30, 2026."},{"key":"2026090306152264000_54.3.252.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.126.272917"},{"key":"2026090306152264000_54.3.252.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-007-0691-z"},{"key":"2026090306152264000_54.3.252.15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s41824-024-00216-6","article-title":"Carcinoid crisis in lutetium-177-Dotatate therapy of neuroendocrine tumors: an overview of pathophysiology, risk factors, recognition, and treatment","volume":"8","author":"Sozio","year":"2024","journal-title":"EJNMMI Rep."},{"key":"2026090306152264000_54.3.252.16","unstructured":"Attachment I, item 19: emergency procedures (revision 103\/08). Nuclear Regulatory Commission website. https:\/\/www.nrc.gov\/docs\/ML0827\/ML082750235.pdf. Accessed July 7, 2026."},{"key":"2026090306152264000_54.3.252.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.125.271963"}],"container-title":["Journal of Nuclear Medicine Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnmt.126.272918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:15:43Z","timestamp":1788441343000},"score":1,"resource":{"primary":{"URL":"http:\/\/tech.snmjournals.org\/lookup\/doi\/10.2967\/jnmt.126.272918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9,3]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.2967\/jnmt.126.272918"],"URL":"https:\/\/doi.org\/10.2967\/jnmt.126.272918","relation":{},"ISSN":["0091-4916","1535-5675"],"issn-type":[{"value":"0091-4916","type":"print"},{"value":"1535-5675","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}